The SIILTIBCY test is now available worldwide through the STOP TB GDF for $1.50 per dose. This novel testing option provides an alternative to PPD testing and is the first MTB antigen based skin test to be approved and recommended by the Global Fund’s Expert Review Panel. This new test has been shown to provide greater specificity in detecting TB in patients who received the BCG vaccine. Read more here.
top of page
Recent Posts
See AllA recent study on the incidence of MDR-TB in children and teens revealed that the prevalence has resurged. there was a 10 year drop from...
The Stop TB Partnership announced a major price reduction on bedaquiline. The cost per treatment course was slashed by over 50%,...
The shutdown and dismantling of USAID has had large ramifications for TB services. As one of the largest funding sources for TB, the...
bottom of page
Comments